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COMBINATION OF VOLITIONAL EXERCISE AND BISPHOSPHONATE TREATMENT IS ABLE TO RESTORE 
BONE LOSS INDUCED BY HINDLIMB SUSPENSION 
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Introduction: It has been previously established in numerous 
radiodensitometric and biochemical studies of human bone and animal 
models that paralysis, immobilization and weightlessness result in loss 
of bone mass or disuse osteoporosis. Loss of bone due to microgravity 
has raised considerable concern about the increased fracture risk of 
astronauts, especially post-menopausal females.1 Despite the serious 
implications of bone loss and fracture fragility of the human skeleton, no 
countermeasure has been clearly established that would maintain bone 
mass during periods of weightlessness. Data from many laboratories 
suggest that exercise2,3,4 and pharmaceuticals (both anti-resorptive and 
anabolic agents)5,6 are capable of restoring bone mass/quality lost due to 
a variety of conditions like aging, menopause/ovariectomy and skeletal 
unloading/disuse. The objective of this research was to determine the 
efficacy of combined interventions of volitional resistance (weight 
lifting) exercise and anti-resorptive pharmacological therapy in reversing 
bone loss in a rat hindlimb suspension model.  
Methods: Male Sprague Dawley rats were obtained from Hilltop 
(Scottdale, PA) at 22 weeks of age. During a training and acclimation 
period of four weeks, the rats were reduced to their proper weight (80% 
of ad libitum feeding weight) and trained to exercise on a previously 
validated volitional resistance-training model.7 At approximately 26 
weeks of age, the rats were assigned randomly to test groups of hindlimb 
suspended (HS) and hindlimb suspended with exercise and Risedronate 
(HSRisEx). After rats were trained, they were hindlimb suspended8,9,10 
using a harness made of a polyester mesh fabric (Harvard Biosciences). 
The exercised rats were released from the suspension system and the lift 
response exercise began and lasted daily for 60 minutes or 80 full lifts, 
whichever came first. The exercise protocol was maintained 5 days per 
week. The hindlimb suspension protocol was continued for 21 days. 
Twice per week, Residronate was injected subcutaneously at a dosage of 
5 mg/kg. Six days prior to sacrifice, Calcein (15 mg/kg) and thirteen 
days prior to sacrifice Democlocycline (15 mg/kg) was administered to 
label bones. The animals were sacrificed by AMVA approved methods. 
The femurs and tibias were excised. The right femur was wrapped in 
saline dampened gauze and frozen for mechanical testing to measure 
breaking load of the femoral neck.11 The left tibia was cut at the mid-
section and both portions placed in formalin for histology. The proximal 
third of the tibias was fixed in 70% ethanol and then embedded 
undecalcified in methyl methacrylate. Frontal sections of the tibia were 
cut to approximately 5 microns using a microtome (RM 2155, Leica, 
Bannockburn, IL). For histomorphometry, a digital image was obtained 
using an Olympus BH-2 microscope and image analysis software 
(Optimas, Edmonds, WA) of each tibial section. Trabecular bone 
volume (TBV) was measured in the primary and secondary spongiosa. 
These results were compared to ground-bearing (GB) and ground-
bearing rats exercised on a treadmill (GBE) groups that were done as 
part of a different study.11 A one-way analysis of variance was used to 
statistically compare groups. 
Essential Results: Mechanical testing for strength of the femoral neck 
revealed significant differences between groups. The ground bearing 
(GB) and ground bearing exercise (GBE) control group had ultimate 
load of 125 N (SD±21.26 N) and 114.55 N (SD±24.28 N), respectively. 
The hindlimb suspended (HS) group had an ultimate load of 82.76 N and 
the combined treatment of exercise and bisphosphonates (HSRisEx) was 
able to bring the ultimate load up to 148.89 N (SD±4.26 N). 
Histomorphometric analysis indicated that TBV was significantly less 
(p<0.05) in HS than in all other groups, which was restored by a 
combination treatment of Exercise and Risedronate (HSRisEx). Mean 
TBV of HSRisEx was slightly greater than in GB and GBE groups but 
the difference was not significant (Figure 1a). An analysis of the 
fluoroscopic images (Figures 1b,c,d) indicated significantly (p<0.0008) 
greater new bone formation in the HSRisEx group than the HS group. 
Discussion: Few studies have looked at the effects of combining 
different therapies. As far as we are aware, only one such study exists 
for rats where exercise and bisphosphonates are combined. Tamaki et 
al.12 examined the effects of treadmill training (TR) following treatment 
with the disphosphonate etidronate (E) in rats with and without 
ovariectomy (ovx). Results indicated that the bone mineral density of the 
femur and the trabecular bone area of the tibia was significantly greater 
in E and/or Tr compared to ovariectomized groups. They concluded that 
the etidronate treatment for two weeks beforehand influenced the effects 
of subsequent exercise training on maintaining BMD in the proximal 
femur and the trabecular bone area of the femur. In another study 
investigating the combined effect of exercise and bisphosphonates in 
humans, Grigoriev et al.13 tested nine bedrest subjects using the exercise 
protocol used by cosmonauts with four of the subjects receiving the 
bisphosphonate ethane-1-hydroxy-1-disphosphonate. The bisphosphona- 
tes combined with exercise reduced negative calcium balance over the 
entire 360-day test period. Exercise alone had no effect until the second 
120 days. Our results seem to support these studies that show that 
bisphosphonates can be effectively used together with exercise to reduce 
calcium loss. This pilot study indicated that combination of therapies 
appears to be feasible to reverse bone loss due to disuse/microgravity. 
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Figure 1. Exercise combined with Risedronate treatment was able to 
rescue trabecular bone volume loss due to hindlimb suspension (a). 
There was also a significant increase in the amount of fluorescent label 
incorporation, indicating enhanced mineral deposition and bone 
formation in the HSRisEx group (b). Fluorescent images of hindlimb 
suspended (c) and HSRisEx (d) bones are shown to emphasize increased 
bone formation. 
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